Franklin Resources Inc Relmada Therapeutics, Inc. Transaction History
Franklin Resources Inc
- $343 Billion
- Q4 2024
A detailed history of Franklin Resources Inc transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 1,302,151 shares of RLMD stock, worth $364,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,302,151
Previous 1,302,151
-0.0%
Holding current value
$364,602
Previous $4.22 Million
83.95%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RLMD
# of Institutions
54Shares Held
8.29MCall Options Held
364KPut Options Held
46.5K-
Vanguard Group Inc Valley Forge, PA1.26MShares$351,8770.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.23MShares$343,8190.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$160,5270.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$138,6400.04% of portfolio
-
Geode Capital Management, LLC Boston, MA303KShares$84,7940.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $8.01M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...